Rhythm Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Rhythm Biosciences has a total shareholder equity of A$1.2M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$1.9M and A$701.1K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$1.26m |
Equity | AU$1.24m |
Total liabilities | AU$701.07k |
Total assets | AU$1.94m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RHY's short term assets (A$1.4M) exceed its short term liabilities (A$679.4K).
Long Term Liabilities: RHY's short term assets (A$1.4M) exceed its long term liabilities (A$21.7K).
Debt to Equity History and Analysis
Debt Level: RHY is debt free.
Reducing Debt: RHY has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RHY has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: RHY is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.